Author index

© 2005 British Society for Immunology, Clinical and Experimental Immunology, 140: 586–591 AABERGE, I.S. see STRAY-PEDERSEN, A. ABRAHAMSEN, T.G. see STRAY-PEDERSEN, A. ADAMS, P. see KRUGER, A. AHLERS, F. see SACHSE, F. AKDIS, C. see AKTAS, E. AKDIS, M. see AKTAS, E. AKTAS, E., AKDIS, M., BILGIC, S., DISCH, R., FALK, C.S., BLASER, K., AKDIS, C. and DENIZ, G. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells, 301 ALESSANDRI, C., BOMBARDIERI, M., DI PROSPERO, L., CONIGLIARO, P., CONTI, F., LABBADIA, G., MISASI, R., SORICE, M. and VALESINI, G. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus, 173 AL-SHANGITI, A.M., NAIR, S.P. and CHAIN, B.M. The interaction between staphylococcal superantigen-like proteins and human dendritic cells, 461 ANDERSON, R. see FICKL, H. ARASON, G.J., KOLKA, R., HREIDARSSON, A.B., GUDJONSSON, H., SCHNEIDER, P.M., FRY, L. and ARNASON, A. Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0, 572 ARCE-PAREDES, P. see ROJAS-ESPINOSA, O. ARKWRIGHT, P.D. see HADLEY, E.A. ARNASON, A. see ARASON, G.J. ASAKA, M. see OHKAWARA, T. ASANO, T. see KANEKO, H. ASHER, D.R. see REPIK, A. AUGUSTO, L.A. see PROULX, L.I. AUKRUST, P. see TORHEIM, E.A. AYED, N.B. see KHALIL, E.A.G. AZZARONE, B. see BRIARD, D.

[1]  R. Schubert,et al.  Growth factor deficiency in patients with ataxia telangiectasia , 2005, Clinical and experimental immunology.

[2]  F. Klebl,et al.  Analysis of intestinal haem‐oxygenase‐1 (HO‐1) in clinical and experimental colitis , 2005, Clinical and experimental immunology.

[3]  M. Sata,et al.  Probiotic Lactobacillus‐induced improvement in murine chronic inflammatory bowel disease is associated with the down‐regulation of pro‐inflammatory cytokines in lamina propria mononuclear cells , 2005, Clinical and experimental immunology.

[4]  H. Schwarz,et al.  Immunomodulatory properties of human serum immunoglobulin A: anti‐inflammatory and pro‐inflammatory activities in human monocytes and peripheral blood mononuclear cells , 2005, Clinical and experimental immunology.

[5]  E. Reyes-Maldonado,et al.  Palsy of the rear limbs in Mycobacterium lepraemurium‐infected mice results from bone damage and not from nerve involvement , 2005, Clinical and experimental immunology.

[6]  D. Sansonno,et al.  Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection , 2005, Clinical and experimental immunology.

[7]  N. Katoh,et al.  The role of interleukin‐16 in murine contact hypersensitivity , 2005, Clinical and experimental immunology.

[8]  C. Rudack,et al.  Neutrophil chemokines in epithelial inflammatory processes of human tonsils , 2005, Clinical and experimental immunology.

[9]  B. Zheng,et al.  Age‐associated deficiency in activation‐induced up‐regulation of telomerase activity in CD4+ T cells , 2005, Clinical and experimental immunology.

[10]  K. Kawakami,et al.  CpG oligodeoxynucleotides promote the host protective response against infection with Cryptococcus neoformans through induction of interferon‐gamma production by CD4+ T cells , 2005, Clinical and experimental immunology.

[11]  M. Sata,et al.  Transgenic over‐expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis , 2005, Clinical and experimental immunology.

[12]  E. Bissonnette,et al.  4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone, a component of tobacco smoke, modulates mediator release from human bronchial and alveolar epithelial cells , 2005, Clinical and experimental immunology.

[13]  M. Brčić,et al.  Evidence for involvement of peptidoglycan in the triggering of an oxidative burst by Listeria monocytogenes in phagocytes , 2005, Clinical and experimental immunology.

[14]  T. Inoue,et al.  In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM‐1 , 2005, Clinical and experimental immunology.

[15]  M. Nolan,et al.  Assessment of CD8+ T cell immune activation markers to monitor response to antiretroviral therapy among HIV‐1 infected patients in Côte d’Ivoire , 2005, Clinical and experimental immunology.

[16]  A. Svennerholm,et al.  Down‐regulation of epithelial IL‐8 responses in Helicobacter pylori‐infected duodenal ulcer patients depends on host factors, rather than bacterial factors , 2005, Clinical and experimental immunology.

[17]  V. Kurup,et al.  Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen , 2005, Clinical and experimental immunology.

[18]  D. Turner,et al.  A role for ab T cells in the resistant phase of the Brown Norway rat model of vasculitis , 2005 .